ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissionsoup.com..
OBJECTIVES: To define guidelines for BK polyomavirus (BKPyV)-associated haemorrhagic cystitis (BKPyV-HC) after paediatric and adult HSCT.
METHODS: Review of English literature and evidence-based recommendations by expert consensus.
RESULTS: BKPyV-HC occurs in 8%-25% of paediatric and 7%-54% of adult recipients undergoing allogeneic HSCT. Diagnosis requires the triad of cystitis, macro-haematuria and high urine BKPyV loads >7 log10 copies/mL, and exclusion of other relevant aetiologies. BKPyV viraemia is frequent and may serve as a more specific semiquantitative follow-up marker. No randomized controlled trials are available to inform antiviral prophylaxis or treatment. However, hyper-hydration and/or bladder irrigation showed limited prophylactic value. Fluoroquinolones are not effective for prophylaxis or treatment, but rather increase antibiotic resistance. Hyperbaric oxygen or fibrin glue is marginally effective based on small case series from correspondingly equipped centres. Although cidofovir has been reported to improve and/or reduce BKPyV viraemia or viruria, the current data do not support its regular use.
CONCLUSIONS: BKPyV-HC remains a disabling unmet clinical need in HSCT that requires novel approaches supported by proper clinical trials.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
The Journal of antimicrobial chemotherapy - 73(2018), 1 vom: 01. Jan., Seite 12-21 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cesaro, Simone [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 31.07.2018 Date Revised 10.04.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jac/dkx324 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM278559379 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM278559379 | ||
| 003 | DE-627 | ||
| 005 | 20231225020856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jac/dkx324 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0928.xml |
| 035 | |a (DE-627)NLM278559379 | ||
| 035 | |a (NLM)29190347 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cesaro, Simone |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.07.2018 | ||
| 500 | |a Date Revised 10.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissionsoup.com. | ||
| 520 | |a OBJECTIVES: To define guidelines for BK polyomavirus (BKPyV)-associated haemorrhagic cystitis (BKPyV-HC) after paediatric and adult HSCT | ||
| 520 | |a METHODS: Review of English literature and evidence-based recommendations by expert consensus | ||
| 520 | |a RESULTS: BKPyV-HC occurs in 8%-25% of paediatric and 7%-54% of adult recipients undergoing allogeneic HSCT. Diagnosis requires the triad of cystitis, macro-haematuria and high urine BKPyV loads >7 log10 copies/mL, and exclusion of other relevant aetiologies. BKPyV viraemia is frequent and may serve as a more specific semiquantitative follow-up marker. No randomized controlled trials are available to inform antiviral prophylaxis or treatment. However, hyper-hydration and/or bladder irrigation showed limited prophylactic value. Fluoroquinolones are not effective for prophylaxis or treatment, but rather increase antibiotic resistance. Hyperbaric oxygen or fibrin glue is marginally effective based on small case series from correspondingly equipped centres. Although cidofovir has been reported to improve and/or reduce BKPyV viraemia or viruria, the current data do not support its regular use | ||
| 520 | |a CONCLUSIONS: BKPyV-HC remains a disabling unmet clinical need in HSCT that requires novel approaches supported by proper clinical trials | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Dalianis, Tina |e verfasserin |4 aut | |
| 700 | 1 | |a Hanssen Rinaldo, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Koskenvuo, Minna |e verfasserin |4 aut | |
| 700 | 1 | |a Pegoraro, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Einsele, Hermann |e verfasserin |4 aut | |
| 700 | 1 | |a Cordonnier, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Hirsch, Hans H |e verfasserin |4 aut | |
| 700 | 0 | |a ECIL-6 Group |e verfasserin |4 aut | |
| 700 | 1 | |a Akova, Murat |e investigator |4 oth | |
| 700 | 1 | |a Aljurf, Mahmoud |e investigator |4 oth | |
| 700 | 1 | |a Averbuch, Dina |e investigator |4 oth | |
| 700 | 1 | |a Barnes, Rosemary |e investigator |4 oth | |
| 700 | 1 | |a Blennow, Ola |e investigator |4 oth | |
| 700 | 1 | |a Bochud, Pierre-Yves |e investigator |4 oth | |
| 700 | 1 | |a Bouza, Emilio |e investigator |4 oth | |
| 700 | 1 | |a Bretagne, Stephane |e investigator |4 oth | |
| 700 | 1 | |a Brüggemann, Roger |e investigator |4 oth | |
| 700 | 1 | |a Calandra, Thierry |e investigator |4 oth | |
| 700 | 1 | |a Carratala, Jordi |e investigator |4 oth | |
| 700 | 1 | |a Cesaro, Simone |e investigator |4 oth | |
| 700 | 1 | |a Cordonnier, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Cornely, Oliver |e investigator |4 oth | |
| 700 | 1 | |a Dalianis, Tina |e investigator |4 oth | |
| 700 | 1 | |a de la Camara, Rafael |e investigator |4 oth | |
| 700 | 1 | |a Donnelly, Peter |e investigator |4 oth | |
| 700 | 1 | |a Drgona, Lubos |e investigator |4 oth | |
| 700 | 1 | |a Duarte, Rafael |e investigator |4 oth | |
| 700 | 1 | |a Einsele, Hermann |e investigator |4 oth | |
| 700 | 1 | |a Engelhard, Dan |e investigator |4 oth | |
| 700 | 1 | |a Fox, Christopher |e investigator |4 oth | |
| 700 | 1 | |a Girmenia, Corrado |e investigator |4 oth | |
| 700 | 1 | |a Groll, Andreas |e investigator |4 oth | |
| 700 | 1 | |a Heldal, Dag |e investigator |4 oth | |
| 700 | 1 | |a Helweg-Larsen, Jannick |e investigator |4 oth | |
| 700 | 1 | |a Herbrecht, Raoul |e investigator |4 oth | |
| 700 | 1 | |a Hirsch, Hans H |e investigator |4 oth | |
| 700 | 1 | |a Johnson, Elisabeth |e investigator |4 oth | |
| 700 | 1 | |a Klyasova, Galina |e investigator |4 oth | |
| 700 | 1 | |a Koskenvuo, Minna |e investigator |4 oth | |
| 700 | 1 | |a Lagrou, Katrien |e investigator |4 oth | |
| 700 | 1 | |a Lewis, Russell E |e investigator |4 oth | |
| 700 | 1 | |a Ljungman, Per |e investigator |4 oth | |
| 700 | 1 | |a Maertens, Johan |e investigator |4 oth | |
| 700 | 1 | |a Mikulska, Malgorzata |e investigator |4 oth | |
| 700 | 1 | |a Nucci, Marcio |e investigator |4 oth | |
| 700 | 1 | |a Padoin, Christophe |e investigator |4 oth | |
| 700 | 1 | |a Pagano, Livio |e investigator |4 oth | |
| 700 | 1 | |a Pagliuca, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Racil, Zdenek |e investigator |4 oth | |
| 700 | 1 | |a Ribaud, Patricia |e investigator |4 oth | |
| 700 | 1 | |a Rinaldo, Christine Hanssen |e investigator |4 oth | |
| 700 | 1 | |a Rizzi-Puechal, Valérie |e investigator |4 oth | |
| 700 | 1 | |a Roilides, Emmanuel |e investigator |4 oth | |
| 700 | 1 | |a Robin, Christine |e investigator |4 oth | |
| 700 | 1 | |a Rovira, Montserrat |e investigator |4 oth | |
| 700 | 1 | |a Rupp, Markus |e investigator |4 oth | |
| 700 | 1 | |a Sanchez, Sonia |e investigator |4 oth | |
| 700 | 1 | |a Schellongowski, Peter |e investigator |4 oth | |
| 700 | 1 | |a Sedlacek, Peter |e investigator |4 oth | |
| 700 | 1 | |a Sinko, Janos |e investigator |4 oth | |
| 700 | 1 | |a Slavin, Monica |e investigator |4 oth | |
| 700 | 1 | |a Ferreira, Isabella Sousa |e investigator |4 oth | |
| 700 | 1 | |a Styczynski, Jan |e investigator |4 oth | |
| 700 | 1 | |a Tissot, Frederic |e investigator |4 oth | |
| 700 | 1 | |a Viscoli, Claudio |e investigator |4 oth | |
| 700 | 1 | |a Ward, Katherine |e investigator |4 oth | |
| 700 | 1 | |a Witschi, Anne-Therese |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of antimicrobial chemotherapy |d 1981 |g 73(2018), 1 vom: 01. Jan., Seite 12-21 |w (DE-627)NLM000017701 |x 1460-2091 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2018 |g number:1 |g day:01 |g month:01 |g pages:12-21 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jac/dkx324 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2018 |e 1 |b 01 |c 01 |h 12-21 | ||